Objective: To investigate the role of miR-21 in cyclooxygenase-2 inhibitor NS398-induced apoptosis and invasion in gastric cancer (GC) cells. Methods: AGS cells were treated with NS398 and transfected with miR-21. Quantitative realtime polymerase chain reaction was used to measure miR-21 mRNA expression. Apoptotic cells were assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling and flow cytometric analysis. The protein expression of cleaved caspase-3, Bcl-2, Bax, Bak, and PTEN was detected by Western blot. The capacities for invasion and migration were measured by transwell and wound-healing assays, respectively. Results: Treatment of AGS cells with NS398 induced apoptosis in a dose-dependent manner accompanied by significant downregulation of miR-21 mRNA expression. Upregulation of miR-21 expression by transfection of miR-21 mimics into AGS cells blocked NS398-induced apoptosis. Treatment of AGS cells with NS398 induced changes in Bcl-2 protein family members, showing an increase in the protein expression of Bax, Bak, and PTEN, with a concomitant decrease in the protein expression of Bcl-2. In cells transfected with miR-21 mimics, these changes were reversed. The decrease in cellular invasiveness and migration induced by NS398 was blocked by upregulation of miR-21. Conclusion: miR-21 mediates anticancer effects of NS398 in GC cells by regulating apoptosisrelated proteins. miR-21 is one of the molecular targets of this specific cyclooxygenase-2 inhibitor in the prevention and treatment of GC.
Introduction
Gastric cancer (GC) is a major health care problem from a global perspective, with 989,000 new GC cases arising annually worldwide. 1 Despite great advances in the diagnosis and treatment of GC, approximately 700,000 people die from GC worldwide each year. 2 Gastric carcinogenesis represents a stepwise progression from chronic inflammation to invasive adenocarcinomas and distant metastasis. Epidemiological evidence indicates that environmental factors play a major role in carcinogenesis. In addition to environmental factors, GC is a complex, multistep process involving deregulation of canonical oncogenic pathways, including the cyclooxygenase-2 (COX-2)/prostaglandin E2 pathway. 3 The COX protein is a key enzyme that catalyzes the formation of prostaglandins and other eicosanoids from arachidonic acid. Two isoforms of COX have been identified: COX-1 and COX-2;
4,5 COX-1 is considered to be a housekeeping gene and is thought to be related to the cytoprotection of gastric mucosa, while COX-2 is an inducible intermediate-early gene, and its roles have been connected to inflammation and carcinogenesis. The expression of COX-2 and prostaglandins has not only been associated with various types of cancer but also been shown to be directly proportional to their aggressiveness. Evidence shows that increased expression of COX-2 is linked to GC development and progression. 7 Thus, inhibition of COX-2 activity has become one of the preferred targets for cancer reduction. 8 Specific COX-2 inhibitors such as NS398 have been investigated as chemopreventive and potentially chemotherapeutic agents. [9] [10] [11] Recent studies have also shown that the COX-2 inhibitor celecoxib has a preventive effect against Helicobacter pylori-associated GC. 12, 13 However, the molecular mechanisms underlying the chemopreventive and chemotherapeutic effects of COX-2 inhibitors remain unclear. In addition to COX-dependent mechanisms, COX-2 inhibitors are known to mediate their effect by COX-independent mechanisms. 14 MicroRNAs (miRNAs) are a newly discovered class of posttranscriptional regulators. They are small noncoding RNAs that are 18-25 nucleotides in length. To date, more than 900 miRNAs have been identified in humans. This class of molecule has the capacity to specifically inhibit translation or induce mRNA degradation, by predominantly targeting the 3′ untranslated regions of mRNA. 15 miRNAs are differentially expressed in various diseases, thus implicating them in normal and pathological molecular mechanisms, 16 and they have been shown to be involved in the pathogenesis of many types of cancer, including GC. 17 Genes coding for these miRNAs have been characterized as novel proto-oncogenes and tumorsuppressor genes based on findings that they control malignant phenotypes such as proliferation, resistance to apoptosis and invasiveness. 18 Among these miRNAs, miR-21 has been demonstrated to influence proliferation, invasion, metastasis, and chemoresistance in different cancer cell lines. [19] [20] [21] [22] miR-21 is one of the most commonly and highly upregulated miRNAs in GC. [19] [20] [21] [22] The expression of miR-21 is significantly increased in GC cases with larger tumor sizes, poor differentiation, metastasis with lymph node involvement, and later stage disease. 22 Overexpression of miR-21 significantly enhances cell proliferation and invasion in GC cells, suggesting that it plays a pivotal role in GC pathogenesis and progression. 23 In this study, we investigated the role of miR-21 in NS398-induced changes of apoptosis, invasiveness, and migration in AGS GC cells and further explored the molecular mechanism. The results show that miR-21 expression is downregulated by treatment with the COX-2 inhibitor NS398, in parallel with GC cell apoptosis. Forced expression of miR-21 reversed changes in apoptosis and invasiveness induced by NS398 in GC cells. miR-21 mediated the changes in the protein expression of Bcl-2, Bax, and Bak induced by NS398. Our results suggest that miR-21 is one of the molecular targets of this specific COX-2 inhibitor in the prevention and treatment of GC.
Methods
This study had ethics approval from the ethics committee of Fudan University, Shanghai, People's Republic of China. 
Materials

cell culture and treatment
The AGS gastric adenocarcinoma cell line was purchased from the American Type Culture Collection (CRL-1739, Rockville, MD, USA). The cells were cultured in Roswell Park Memorial Institute (RPMI)-1640 medium (11875; Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (10099-141, Thermo Fisher Scientific) and a 1% antibiotic-antimycotic solution at 37°C in a humidified 5% CO 2 incubator. Cells were passaged every 5 days by washing twice in 5 mL phosphate-buffered saline (PBS), then incubating with 0.25% trypsin. The COX-2 inhibitor NS398 (Cayman Chemical Company, Ann Arbor, MI, USA) dissolved in RPMI-1640 medium (0, 50, and 100 µM/L) was added to AGS cells inoculated into a six-well plate. NS398 was dissolved in dimethyl sulfoxide, and the control group was treated with dimethyl sulfoxide alone at a final concentration of 0.1%.
The study comprised five experimental groups: NS398 group (50 and 100 µM/L), NS398 (100 µM/L) + miRNA-NC (negative control), NS398 (100 µM/L) + miR-21 mimics, and normal control. In the NS398 (100 µM/L) + miRNA-NC (negative control) and NS398 (100 µM/L) + miR-21 mimics groups, NS398 was added 24 hours after transfection of miR-21 mimics or miRNA-NC. MA, USA). Cells with mutant mimics and miRNA-NC without addition of NS398 were used as the randomized and blank control groups respectively. To perform the transfection, 100 pmol of the mimics were diluted in 250 µL of serum-free RPMI-1640 medium, and then 5 µL of Lipofectamine ® 2000 were diluted in another 250 µL serum-free RPMI-1640 medium. After incubating at room temperature for 5 minutes, the two agents were mixed gently and incubated at room temperature for 20 minutes. The resulting complexes were added to the cells and incubated overnight at 37°C in an atmosphere of 5% CO 2 . In subsequent experiments, the medium was replaced with the same medium containing 10% fetal bovine serum. Total RNAs and proteins were extracted for analysis 24 hours after transfection.
Quantitative real-time polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific) for miR-21 mRNA analyses. For the detection of miR-21 expression, stem-loop quantitative real-time polymerase chain reaction (qRT-PCR) was performed using SYBR Premix Ex Taq™ (TaKaRa, Shiga, Japan) according to the manufacturer's protocol. Based on the sequence of miR-21, a stem-loop RT primer was designed with the following sequence: 5′-GTCGTATCCAGTGCAGGGTCC GAGGTATTCGCACTGGATACGACTCAACA-3′. One microgram of total RNA was reverse transcribed by under the following reaction conditions: 16°C for 30 minutes, 30°C for 5 minutes, 42°C for 30 minutes, 85°C for 5 minutes. The primer for U6 was: 5′-CTCGCTTCGGCAGCACA-3′ (forward); 5′-AACGCTTCACGAATTTGCGT-3′ (reverse). The qRT-PCR conditions were: 94°C for 30 seconds, 94°C for 10 seconds, 60°C for 30 seconds, for 40 amplification cycles. All qRT-PCR experiments were performed in triplicate and the experiments were repeated three times. Quantification of expression of each target was compared with untreated controls using the 2 −∆∆Ct method. U6 was used as a control.
Western blot analysis
Proteins were analyzed by Western blot as previously described. 24 AGS cells were plated at a density of 1×10 5 cells/ well in six-well plates. At 24 hours after treatment, the cells were washed with ice-cold PBS and lysed with lysis buffer. The cell lysate (50 µg protein) was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the protein bands were transferred to a polyvinylidene difluoride membrane. The membrane was blocked with Tris-buffered saline containing 0.1% Tween 20 and 5% nonfat, dry milk for 1 hour, and then incubated overnight at 4°C with the primary antibody (1:1,000). The membrane was washed three times with PBS containing 0.1% Tween 20, and incubated with horseradish peroxidase-conjugated anti-rabbit immunoglobulin G as the secondary antibody (1:7,000) for 1 hour at room temperature. Protein bands were detected using the enhanced chemiluminescence system and analyzed using densitometry. Quantitative analysis was performed with beta-actin as an internal control.
Flow cytometry
Apoptotic cells were assessed using Annexin V staining, which was performed according to the protocol provided by the manufacturer. The cells were treated with different treatments for 48 hours, at the end of which a total of 10 5 cells was harvested by trypsinization and washed twice in ice-cold PBS. The cells were then suspended in 400 µL Annexin V-fluorescein isothiocyanate (FITC) binding buffer containing 5 µL Annexin V-FITC and incubated at 37°C for 10 minutes. After this, the cells were resuspended in 190 µL Annexin V-FITC binding buffer with 10 µL propidium iodide. The apoptotic cells were analyzed by flow cytometry within an hour.
TUnel assay
DNA breaks occur later in the apoptotic pathway and can be determined and analyzed by performing the terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling (TUNEL) assay (Kaiji Biotech, Nanjing, People's Republic of China). First, a total of 10 5 cells were seeded onto coverslips after transfection with miR-21 mimics and treated with 100 µM/L NS398. For analysis, the cells were washed, fixed, and stained as per the manufacturer's instructions and apoptotic numbers evaluated using a confocal laser scanning microscope at 515-565 nm.
Transwell assay
The transwell assay was performed as previously described. 25 In brief, 100 µL of diluted matrigel (BD, Franklin Lakes, NJ, USA) was added to the upper chamber of wells of a 24-well transwell plate (Corning Incorporated, Corning, NY, USA). After the matrigel polymerized, 100 µL of cell suspension (1×10 5 cells/mL) was plated into the upper chamber, and 500 µL of RPMI-1640 medium containing 10% serum was added to the lower chamber. The cells were incubated for 24 hours. At the end of the incubation period, cells that could not migrate or invade through the pores were removed using a cotton swab. Filters were fixed with 90% ethanol, stained with 0.1% crystal violet (Beyotime Institute of submit your manuscript | www.dovepress.com
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. Cells adhering to the lower chamber surface were quantified by visualizing five random fields at a magnification of ×200 and averaging as described.
Wound-healing assay
AGS cells were seeded into six-well plates (1×10 5 cells/well) and allowed to grow to confluence. Confluent monolayers were scratched with a pipette tip. Plates were washed three times with PBS to remove nonadherent cells and serum-free RPMI-1640 medium was added. The six-well plates were then incubated at 37°C, 5% CO 2 for 24 hours, and then photographed.
statistical analysis
All data were analyzed using SPSS 11.5 software (SPSS Inc., Chicago, IL, USA). The results are expressed as mean ± SEM. Analysis of variance, followed by Bonferroni's t-test, was used to evaluate differences among groups. P,0.05 was considered significant.
Results
ns398 induced apoptosis and decreased invasiveness accompanied by downregulation of mir-21 expression in ags cells
To investigate the effects of NS398 in AGS cells, we performed flow cytometry and TUNEL assay. Flow cytometry showed that the proportion of apoptotic cells in the control group, the 50 µM/L group, and the 100 µM/L group was 2.98%±0.2%, 5.15%±0.1%, and 10.6%±0.2%, respectively. The rates of apoptosis in the treatment groups were significantly higher than in the control group (P,0.05) ( Figure 1A ).
In the TUNEL assay, apoptosis-negative nuclei were stained blue. The cells positive for apoptosis presented with bigger nuclei that were brown in color. The apoptotic rates of the control group, the 50 µM/L group, and the 100 µM/L group were 2.06%±0.3%, 9.36%±1.5%, and 14.39%±1.7%, respectively. The rates of apoptosis in the treatment groups were significantly higher than in the control group (P,0.05) ( Figure 1B) . Treatment of AGS cells with NS398 induced apoptosis in a dose-dependent manner.
Next, we further assessed the effects of NS398 on cell migration, a key determinant of malignant progression and metastasis. We found that NS398 could significantly reduce the migratory abilities of AGS cells in the scratch woundhealing motility assay ( Figure 1C ). In addition, the invasive capacity of AGS cells was reduced by 66.3% compared to the control group, with a mean of 41 cells versus 122 cells per six random microscopic fields (P,0.05) ( Figure 1D ).
Finally, we tested whether NS398 affected the expression of miR-21 in AGS cells. In our study, the relative expression level of miR-21 was determined by qRT-PCR after the AGS cells were exposed to different concentrations of NS398. Treatment of AGS cells with NS398 significantly downregulated miR-21 expression ( Figure 1E ). These results suggested that miR-21 might be involved in NS398-induced anticancer effects in AGS cells.
mir-21 reversed the changes of apoptosis, migratory, and invasive abilities induced by ns398 in ags cells
In order to confirm the role of miR-21 in NS398-induced apoptosis and inhibition of the invasiveness and migration in AGS cells, we investigated the effect of miR-21 overexpression on NS398-induced anticancer effects. The results showed that the expression of miR-21 was significantly increased after transfection of miR-21 mimics into AGS cells (Figure 2A) .
Flow cytometric assay showed that the apoptotic rates of the NS398 (100 µM/L) group, NS398 (100 µM/L) + miRNA-NC group, NS398 (100 µM/L) + miR-21 mimics group were 10.33%±0.1%, 11.17%±0.1%, and 6.49%±0.2%, respectively. The rates of apoptosis in the miR-21 mimic groups were significantly lower than in the control group (P,0.05) ( Figure 2B ).
The TUNEL assay showed that the apoptotic rates of the miR-21 NC group and the miR-21 mimic group were 12.19%±0.2% and 14.28%±0.8%, respectively. The rate of apoptosis in the miR-21 mimic group was significantly lower than in the control group (P,0.05) ( Figure 2C ).
In addition, we further assessed the effects of miR-21 mimics on cell migration, a key determinant of malignant progression and metastasis. We found that miR-21 mimics could significantly increase the migratory abilities of AGS cells in the scratch wound-healing motility assay ( Figure 2D ). The invasive capacity of AGS cells in the miR-21 mimics group was increased by 82% compared to the miR-21 NC group, with a mean of 86 cells versus 47 cells per six random microscopic fields (P,0.05) ( Figure 2E ). These results suggest that miR-21 mediates the anticancer effects of NS398.
mir-21 mediates anticancer effects of ns398 by regulating the protein expression ratio of Bcl-2/Bax and PTen
In order to further explore the molecular mechanisms of action of miR-21 on NS398-induced anticancer effects, we investigated the role of miR-21 in NS398-induced changes in the protein expression of Bcl-2 family members, caspase-3, and PTEN. Treatment of AGS cells with NS398 resulted in a significant decrease in Bcl-2 protein expression and an increase in Bax and Bak protein expression. In addition, caspase-3, which is a downstream target of the Bcl-2 family, was activated by the treatment with NS398. Finally, the protein expression of PTEN was also increased. However, these changes induced by NS398 treatment were reversed with the overexpression of miR-21. The results indicate that miR-21 mediates the anticancer effects of NS398 by regulating the protein expression ratio of Bcl-2/Bax and PTEN ( Figure 3 ).
Discussion
NS398, a specific COX-2 inhibitor, has chemopreventive effects in gastrointestinal cancers. 9, 10 Previous studies showed that NS398 could effectively inhibit proliferation 26 miR-21 has been shown to be implicated in multiple malignancy-related processes including cell proliferation, apoptosis, invasion, and metastasis. 27, 28 High expression of miR-21 increases tumor cell proliferation, invasion, viability, and migration in lung squamous cell carcinoma. 29 miR-21 was first implicated as an antiapoptotic factor by the observation that knockdown of miR-21 increased apoptotic cell death in human glioblastoma cells. 30 However, the role of miR-21 in anticancer effects induced by specific COX-2 inhibitors has not been investigated in GC. In the present study, we used a specific COX-2 inhibitor, NS398, and showed that the expression level of miR-21 in AGS cells was reduced after NS398 treatment. We evaluated the apoptosis, migration, and invasion of AGS cells with miR-21 overexpression or NS398 treatment, and showed that increased miR-21 expression could reduce NS398-induced anticancer effects in AGS cells. The results showed that miR-21 could mediate the anticancer effects of NS398.
A study has affirmed that miR-21 inhibits the apoptosis of GC cell lines. 31 However, the mechanisms of miR-21-mediated NS398-induced cell apoptosis are not yet fully understood. Bcl-2 protein family members including Bcl-2, Bax, and Bak should be attractive biomarkers of apoptosis. Previous studies have shown that treatment with NS398 changes the expression of proapoptotic Bax and antiapoptotic Bcl-2 involved in the mitochondrial pathway of apoptosis in GC cells. 26, 32 Shi et al showed that miR-21 overexpression appeared to downregulate Bax expression, and upregulate Bcl-2 expression. 33 Our studies examined the expression of Bax and Bcl-2 proteins in AGS cells following treatment with NS398 and miR-21 overexpression. Our results show that the treatment of cells with NS398 decreases the upregulation of Bax and Bak expression and increases the downregulation of Bcl-2 expression. Cells transfected with miR-21 mimics reverse these changes. These findings suggest a markedly inhibitory effect of miR-21 overexpression on NS398-mediated regulation in Bax/Bcl-2 ratios.
Caspase proteins are cysteine proteases that act downstream of the Bcl-2 family by initiating cellular breakdown during apoptosis. The caspases, especially caspase-3, are known to act downstream of Bax/Bcl-2 and play a key role in the execution of apoptosis. 34 Among the effector caspases, caspase-3 is most frequently involved in neuronal apoptosis. Our results show that the treatment of cells with NS398 appears to increase caspase-3 activity compared to the control group. However, this effect of caspase-3 activity induced by NS398 treatment is prevented by miR-21 overexpression.
These results indicate that miR-21 overexpression can inhibit apoptosis induced by NS398 through regulating caspase-3 activity.
PTEN is an important tumor suppressor gene and the functional inactivation of PTEN by regulation of its expression is relevant to many solid tumors. PTEN is involved in GC pathology and its downregulation can lead to resistance to chemotherapeutic drugs including cisplatin in GC patients. 35 Loss of functional PTEN leads to increased activity of AKT and mammalian target of rapamycin kinase pathways, which can promote both cell survival and proliferation through phosphorylation and inactivation of several downstream mediators. 36 PTEN is a well-established downstream target of miR-21. 37 More importantly, we demonstrate that the effect of cellular migration, invasion, and PTEN levels inhibited by NS398 treatment is partly prevented by miR-21 overexpression. These results indicate that miR-21 mediates cellular migration and invasion induced by NS398 through regulating the protein expression of PTEN.
Conclusion
This study demonstrates that miR-21 mediates anticancer effects of NS398 in GC cells by regulating apoptosis-related proteins. miR-21 is one of the molecular targets of a specific COX-2 inhibitor in the prevention and treatment of GC.
